# ANX-042 Healthy Volunteer Dose Escalation Study

> **NCT01638104** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ANX-042
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01638104
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-10-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01638104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01638104, "ANX-042 Healthy Volunteer Dose Escalation Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01638104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*